Venue Analysis Following 1st Chinese Patent Office Rulings
The China National Intellectual Property Administration recently made two benchmark administrative rulings in a major patent infringement dispute. The case was brought by international innovator drug company Boehringer Ingelheim Pharma GmbH...To view the full article, register now.
Already a subscriber? Click here to view full article